Financial Reports
Related Searches:
Filter by:
October 19, 2007
Gilead Sciences
3Q Revenues: $1.1 billion (+41%)
3Q Earnings: $398 million (net loss of $52 million in 3Q06)
YTD Revenues: $3.1 billion (+47%)
YTD Earnings: $1.2 billion (+155%)
Comments: Sales of new HIV medication Atripla reached $24…
Read More »
October 18, 2007
Pfizer
3Q Revenues: $12.0 billion (-2%)
3Q Earnings: $761 million (-77%)
YTD Revenues: $35.6 billion (-1%)
YTD Earnings: $5.4 billion (-45%)
Comments: 3Q Pharma sales dropped 4% to $11.0 billion. Ongoing generic erosion from Zoloft (Ju…
Read More »
October 18, 2007
Wyeth
3Q Revenues: $5.6 billion (+9%)
3Q Earnings: $1.1 billion (flat)
YTD Revenues: $16.6 billion (+10%)
YTD Earnings: $3.6 billion (+8%)
Comments: 3Q pharma revenues were up 10% to $4.7 billion, driven by a 24% boost in sales of Prev…
Read More »
October 18, 2007
Novartis
3Q Revenues: $9.6 billion (+9%)
3Q Earnings: $6.8 billion (+267%)
YTD Revenues: $28.1 billion (+13%)
YTD Earnings: $11.0 billion (+100%)
Comments: Net earnings included $5.2 billion from the sale of the Medical Nutrition and G…
Read More »
October 17, 2007
Abbott Laboratories
3Q Revenues: $6.4 billion (+14%)
3Q Earnings: $717 million (flat)
YTD Revenues: $18.7 billion (+15%)
YTD Earnings: $2.4 billion (+10%)
Comments: Pharma sales grew 20% to $3.5 billion in 3Q07, driven by growth in Hu…
Read More »
October 16, 2007
Genentech
3Q Revenues: $2.9 billion (+22%)
3Q Earnings: $685 million (+33%)
YTD Revenues: $8.8 billion (+21%)
YTD Earnings: $2.1 billion (+41%)
Comments: U.S. product sales were $2.2 billion in the quarter, up 18%. Avastin sales w…
Read More »
October 16, 2007
Johnson & Johnson
3Q Revenues: $15 billion (+13%)
3Q Earnings: $2.5 billion (-8%)
YTD Revenues: $45.1 billion (+14%)
YTD Earnings: $8.2 billion (-8%)
Comments: Worldwide pharmaceutical sales were $6.1 billion in the quarter,…
Read More »
September 19, 2007
Catalent Pharma Solutions
4Q Revenues: $451.3 million (+5%)
4Q Loss: $168.7 million (earnings were $27.6 million 4Q2006)
FY Revenues: $1.7 billion (+6%)
FY Loss: $127.3 million (earnings were $51 million FY2006)
Comments: FY and 4Q revenue…
Read More »
August 9, 2007
BASi
3Q Revenues: $12.6 million (26%)
3Q Earnings: $449,000 (loss of $1.8 million 3Q2006)
YTD Revenues: $34.8 million (+8%)
YTD Earnings: $1.1 million (loss of $1.9 million YTD2006)
Comments: Revenue growth was driven by a $2.7…
Read More »
August 9, 2007
Abraxis BioScience, Inc.
2Q Revenue: $242.5 million (+51%)
2Q Earnings: $23.1 (loss of $90.8 million 2Q2006)
YTD Revenues: $454.7 million (+49%)
YTD Earnings: $34.2 (loss of $88.9 million YTD2006)
Comments: In the quarter, Abraxan…
Read More »
August 8, 2007
Hospira
2Q Revenues: $869.4 million (+29.5)
2Q Earnings: $30.7 million (-43%)
YTD Revenues: $1.7 billion (+24%)
YTD Earnings: $1.3 million (-99%)
Comments: Pharmaceutical contract manufacturing revenues were $36.9 million in the q…
Read More »
August 2, 2007
AMRI
2Q Revenues: $49.4 million (+8%)
2Q Earnings: $4.6 million (loss of $353,000 in 2Q2006)*
YTD Revenues: $97.7 million (+10%)
YTD Earnings: $7.8 million (earnings were $1.5 million YTD2006)
Comments: Contract revenue in the q…
Read More »
July 27, 2007
Amgen
2Q Revenues: $3.7 billion (+3%)
2Q Earnings: $1 billion (earnings were $14 million in 2Q2006)
YTD Revenues: $7.4 billion (+9%)
YTD Earnings: $2.1 billion (+110%)
Comments: Worldwide sales of Aranesp were down 10% to $949 mi…
Read More »
July 26, 2007
Bristol-Myers Squibb
2Q Revenues: $4.9 billion (+1%)
2Q Earnings: $706 million (+6%)
YTD Revenues: $9.4 billion (-1%)
YTD Earnings: $1.4 billion (flat)
Comments: Worldwide pharmaceutical sales were flat at $3.9 billion. U.S.…
Read More »
July 24, 2007
Eli Lilly & Co.
2Q Revenues: $4.6 billion (+14%)
2Q Earnings: $664 million (-19%)
YTD Revenues: $8.9 billion (+13%)
YTD Earnings: $1.2 billion (-29%)
Comments: Net income was impaired by the purchases of Hypnion and Ivy Animal Heal…
Read More »
